This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring :
- Timothy A. Wurst, MBA, Vice President for Clinical Research and Regulatory Affairs, TVAX Biomedical, LLC
Related Videos:
- Prima BioMed Presentation at Cancer Immunotherapy Conference
- BioSante Presentation at Cancer Immunotherapy Conference
- Bavarian Presentation at Cancer Immunotherapy Conference
- Biovest International Presentation at Cancer Immunotherapy Conference
- Vaccinogen Presentation at Cancer Immunotherapy Conference
- Inovio Presentation at Cancer Immunotherapy Conference
- Argos Therapeutics Presentation at Cancer Immunotherapy Conference
- Provectus Presentation at Cancer Immunotherapy Conference
- Celldex Presentation at Cancer Immunotherapy Conference
- Dendreon Presentation at Cancer Immunotherapy Conference

One Trackback
[...] TVAX Biomedical Autologous Approaches [...]